Abstract
The low amount of antifungal agents that can be used in clinical practice nowadays, plus the fact that fungi are eukaryotes, presenting very small physiological differences when compared to humans, unlikely other non-eukaryotic parasites, turns out to be necessary the existence of more studies contemplating the development of new safe antifungal drugs. There are three classes of antifunga…